Federal award (DELIVERY ORDER, fiscal year 2023)
Recipient: MIDNIGHT SUN TECHNOLOGIES LLC
Awarding agency: Department of Health and Human Services / Food and Drug Administration
Funding agency: Department of Health and Human Services / Food and Drug Administration
Period of performance: 2021-09-16 to 2022-11-15
Current total value of award: $102240
Description: A PRIMARY MISSION AT FDA?S CENTER FOR BIOLOGICS EVALUATION AND RESEARCH IS TO PROTECT AND ADVANCE PUBLIC HEALTH BY ENSURING THE SAFETY AND EFFICACY OF THERAPEUTIC PROTEINS, INCLUDING PLASMA PROTEIN-BASED THERAPIES USED FOR COVID19 INFECTION. TO SUPPO